Company news
Precision Peptide Company Inc news
Latest news releases, newest first.
The Precision Peptide Company's Needle-Free First Strategy Already in Place as HHS Draft Policy Recognizes Non-Injectable Routes for Leading Peptides
November 3, 2026
The Precision Peptide Company Quadruples U.S. Telehealth Formulary to 16 Prescription Therapies Across Seven Therapy Areas
October 29, 2026
The Precision Peptide Company Highlights 30 Years of Peptide Science Behind Its Product Platform
October 28, 2026
The Precision Peptide Company Locks In Exclusive Manufacturing Rights Across Its Needle-Free Line
October 22, 2026
The Precision Peptide Company Begins Development of GLP3 Patch, Its Fourth Needle-Free Peptide
October 20, 2026
The Precision Peptide Company Advances Needle-Free GLP-1 Tirzepatide Patch into Formal U.S. Testing
October 13, 2026
The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch
October 7, 2026
The Precision Peptide Company Expands U.S. Wholesale Program, Opening Distribution of Its Needle-Free Range to Clinics, Med Spas, Gyms and Retailers
September 29, 2026
The Precision Peptide Company Announces Digital Marketing and Advertising Services Agreements
September 10, 2026
The Precision Peptide Company Advances Thymosin Alpha-1 Patch into Formal U.S. Testing
September 8, 2026
The Precision Peptide Company Announces Grants of RSUs and Stock Options
September 4, 2026
The Precision Peptide Company to Showcase Its Needle-Free Recovery Patch and Supplement Range at FitExpo Anaheim
August 25, 2026
The Precision Peptide Company Inc. Announces Development of Needle-Free Tirzepatide Transdermal Patch
August 19, 2026
The Precision Peptide Company Completes Migration of Amino Innovations Online Store and Customer Base to Company Website
August 7, 2026
The Precision Peptide Company Targets Launch of the Peptide Pen, Expanding Its U.S.-Made Product Platform
August 4, 2026
The Precision Peptide Company Opens Nationwide Retail Sales Days After FDA Panel Backs Six of Seven Peptides Under Review
July 30, 2026
The Precision Peptide Company Advances First-to-Market Thymosin Alpha-1 Patch for Immune Support
July 28, 2026
The Precision Peptide Company Applauds FDA Advisory Committee Vote on Expanded Pathway for BPC-157 and KPV
July 24, 2026
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch
July 21, 2026
The Precision Peptide Company Inc. Announces Closing of LIFE Offering of Common Shares
July 15, 2026
The Precision Peptide Company Inc. Receives 20,000-Unit Production Run of BPC-157 Transdermal Patches
July 14, 2026
The Precision Peptide Company Appoints Certified Peptide Therapist and Integrative Health Coach Diane Stafrace to Advisory Board
July 3, 2026
The Precision Peptide Company's Needle-Free Recovery Patch Featured in Men's Health Magazine
June 30, 2026
The Precision Peptide Company Achieves LegitScript Healthcare Merchant Certification
June 23, 2026
The Precision Peptide Company Announces Release of The Human Upgrade with Dave Asprey Episode Featuring Chief Scientific Officer Justin Kirkland
June 16, 2026
The Precision Peptide Company Inc. Announces up to $2 Million LIFE Offering of Common Shares
June 11, 2026
The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership
June 9, 2026
The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC
June 5, 2026
The Precision Peptide Company Inc. Signs Agreement with U.S.-Based 503A Sterile Compounding Pharmacy - Peptides to be 100% Compounded in the United States
June 2, 2026
The Precision Peptide Company to Exhibit as the Only Peptide Company at Dave Asprey's BEYOND Conference in Austin, Texas
May 28, 2026
The Precision Peptide Company Inc. Places Order for 20,000 BPC-157 Transdermal Patches
May 26, 2026
The Precision Peptide Company (BPC) Expands on Exclusive 50/50 Revenue Share Peptide Partnership with MMA.INC (MMA)
May 21, 2026
The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch
May 19, 2026
The Precision Peptide Company Inc. Announces Exclusive Strategic Marketing Partnership with Mixed Martial Arts Group Limited
May 12, 2026
The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances
May 7, 2026
C$1.3 Million in Proceeds Received by The Precision Peptide Company from Warrant Exercises
May 5, 2026
The Precision Peptide Company Grants RSUs and Stock Options and Settles Debt
May 4, 2026
The Precision Peptide Company Announces Strategic Product Marketing Agreement
April 23, 2026
The Precision Peptide Company Applauds FDA Action Advancing Regulatory Clarity for Peptide Therapies
April 16, 2026
The Precision Peptide Company Announces Public Relations and Consulting Services Agreement
April 15, 2026
The Precision Peptide Company Launches New Corporate Website and Comments on Evolving U.S. Policy in Support of Peptide-Based Therapies
April 7, 2026
Decks
- The Precision Peptide Company — Investor Presentation (August 2026)
Investor deck · 21 slides · August 2026